Clinical Trials Directory

Trials / Conditions / High Grade Serous Ovarian Cancer

High Grade Serous Ovarian Cancer

21 registered clinical trials studyying High Grade Serous Ovarian Cancer — 11 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT07503808
IDEAYA BiosciencesPhase 1
Not Yet RecruitingMinimal Residual Disease in Solid Malignancies
NCT07268469
European Institute of OncologyN/A
Not Yet RecruitingImpact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
NCT07269574
Tongji Hospital—
RecruitingInvestigating Idetrexed and Olaparib in Patients With Ovarian Cancer
NCT06976892
Institute of Cancer Research, United KingdomPhase 1
RecruitingRole of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma
NCT06777082
IRCCS Azienda Ospedaliero-Universitaria di Bologna—
RecruitingUnravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195
Institut du Cancer de Montpellier - Val d'AurelleN/A
RecruitingA Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
NCT05512208
University of OklahomaPhase 2
RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
GenmabPhase 1 / Phase 2
RecruitingEfficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherap
NCT05281471
Genelux CorporationPhase 3
TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
NCT05329545
Mersana TherapeuticsPhase 3
WithdrawnBreast Cancer BRCA1 Carriers: a Pilot Study
NCT05062174
Indiana University—
RecruitingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Hea
NCT05005403
AbbViePhase 1
UnknownmiRNAs in High Grade Serous Ovarian Cancer
NCT05146505
IRCCS Azienda Ospedaliero-Universitaria di Bologna—
RecruitingCtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
NCT05027828
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine—
UnknownNUVOLA TRIAL Open-label Multicentre Study
NCT04261465
Fondazione Policlinico Universitario Agostino Gemelli IRCCSPhase 2
CompletedPembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer
NCT05188781
The Affiliated Hospital of Qingdao University—
Completedp53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246
NCT03268382
Aprea TherapeuticsPhase 2
Active Not Recruiting"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Ca
NCT01883297
University Health Network, TorontoPhase 1
CompletedOpen Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects
NCT02307240
Curis, Inc.Phase 1
CompletedA Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid
NCT01853306
AbbViePhase 1
No Longer AvailableExpanded Access to Veliparib
NCT03123211
AbbVie—